The main aims of this study were to study the patterns of mutations in rpoB, katG, and inhA genes in strains isolated from patients from Nepal and to evaluate the performance of genotype MTBDRplus assay, taking conventional drug susceptibility testing as gold standard for diagnosis of MDR-TB. A total of 69 strains isolated from 73 smear positive sputum samples from patients suspected of suffering from multidrug-resistant tuberculosis were used in our study. The drug susceptibility pattern of isolated from these sputum specimens was determined by using genotype MTBDRplus assay taking conventional drug susceptibility testing as reference. The sensitivity and specificity of the genotype MTBDRplus assay for the detection of MDR-TB were found to be 88.7% and 100%, respectively. 88.7% of the rifampicin resistant isolates had mutations in rpoB gene. Similarly, 79.7% and 9.4% of isoniazid resistant isolates had mutations in katG and inhA genes, respectively. Genotype MTBDRplus assay was found to be very rapid and highly sensitive and specific method for diagnosis of MDR-TB and will be very helpful for early diagnosis of MDR-TB in high tuberculosis burden countries.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572086 | PMC |
| http://dx.doi.org/10.1155/2017/1635780 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Diagnostic Accuracy of FluoroCycler XT MTBDR Assay for Detection of Rifampicin and Isoniazid-resistant Mycobacteria tuberculosis in Clinical Isolates from Kenya.
Int J Mycobacteriol
July 2024
National Tuberculosis Reference Laboratory, National Public Health Laboratories, Nairobi, Kenya.
Background: Drug-resistant tuberculosis (DR-TB) poses a major global challenge to public health and therapeutics. It is an emerging global concern associated with increased morbidity and mortality mostly seen in the low- and middle-income countries. Molecular techniques are highly sensitive and offer timely and accurate results for TB drug resistance testing, thereby positively influencing patient management plan.
View Article and Find Full Text PDFEvaluation of GeneNAT Real-Time Polymerase Chain Reaction Analyzer and Pre-loaded Chip-Based Mycobacterium tuberculosis and Multidrug-Resistant Tuberculosis Detection in the Diagnosis of Pulmonary Tuberculosis.
Cureus
July 2024
Internal Medicine, All India Institute of Medical Sciences, New Delhi, IND.
Background: Tuberculosis (TB) is still the second causative agent of death worldwide after COVID-19. It is caused by (MTB) infection.
Objective: The aim of the current study was to compare the performance of GeneNAT real-time polymerase chain reaction analyzer and pre-loaded chip-based MTB screening and multidrug-resistant tuberculosis (MDR-TB) detection kit (Smart Sure MTB & MDR-TB, Genetix Biotech Asia Pvt.
Molecular Epidemiology of Isoniazid-resistant in Port-au-Prince, Haiti.
Open Forum Infect Dis
August 2024
Center for Global Health, Weill Cornell Medicine, New York, New York, USA.
Background: Isoniazid-resistant, rifampin-susceptible tuberculosis (Hr-TB) is associated with poor treatment outcomes and higher rates of acquisition of further drug resistance during treatment. Due to a lack of widespread diagnostics, Hr-TB is frequently undetected and its epidemiology is incompletely understood.
Methods: We studied the molecular epidemiology of Hr-TB among all patients diagnosed with culture-positive pulmonary tuberculosis between January 1 and June 30, 2017, at an urban referral tuberculosis clinic in Port-au-Prince, Haiti.
Mutational analysis in drug resistant Mycobacterium tuberculosis in Western Uttar Pradesh.
Indian J Tuberc
July 2024
Department of Microbiology, Subharti Medical College, Swami Vivekanand Subharti University Meerut, UP, India. Electronic address:
Background: Multi-drug resistant tuberculosis (MDR-TB) results in treatment failure and poor clinical outcomes. This study was carried out with the aim to determine the pattern of drug resistance against Mycobacterium tuberculosis towards first line ATT (anti-tubercular treatment) in sputum smear-positive patients using Line Probe Assay (LPA).
Methods: A cross sectional prospective study was carried out in a tertiary care Hospital of Meerut.
Drug resistance profiles of clinical isolates by genotype MTBDRplus line probe assay in Zambia: findings and implications.
JAC Antimicrob Resist
August 2024
Technical Services, Ministry of Health Headquarters, Lusaka, Zambia.
Background: The emergence of drug resistance is a threat to global tuberculosis (TB) elimination goals. This study investigated the drug resistance profiles of () using the Genotype MTBDRplus Line Probe Assay at the National Tuberculosis Reference Laboratory (NTRL) in Zambia.
Methods: A cross-sectional study was conducted between January 2019 and December 2020.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!